28 October 2020
Freemasons New Zealand have renewed their support of the Institute’s CAR T-cell programme, pledging a further $600,000 over the next three years.
The CAR T-cell team with Freemasons New Zealand
Freemasons New Zealand Grand Master Graham Wrigley says Freemasons New Zealand are proud to continue to support the Institute’s work because it is practical research that will have real outcomes that have the potential to improve the lives of all New Zealanders.
“Freemasons New Zealand donate extensively to medical research programmes like this CAR T-cell research because they are a promising and effective way that we can do something tangible to help New Zealanders. Our support is motivated by the guiding principles that underpin Freemasonry, particularly compassion and love of, and support for, humankind.”
Director of the Malaghan Institute professor Graham Le Gros says the financial partnership with the Freemasons provides a significant and vital boost to the Institute’s CAR T-cell research.
“As an independent research organisation and charity, the Malaghan Institute relies on support from the community and the generosity of organisations like Freemasons whose support, along with that of other organisations, will allow us to accelerate the availability of this ground-breaking treatment in New Zealand.”
Related articles
Developing next generation CAR T-cell therapies for more equitable cancer care
30 October 2025
Eradicating H. Pylori bacterial infection to reduce stomach cancer
30 October 2025
Making local impact using global training in liver cancer research
30 October 2025
Faster CARs: overcoming cellular exhaustion to enhance cancer immunotherapies
29 October 2025
Improving immunotherapies for lung cancer
29 October 2025
Malaghan CAR T programme wins KiwiNet Research Commercialisation Award
23 October 2025